
Glufin P 1mg/500mg/15mg Tablet
Marketer
Sarthi Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glufin P 1mg/500mg/15mg Tablet
DiaBeta Trio (1mg/500mg/15mg) tablets offer a multi-component approach to managing blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. Its mechanism involves improving insulin effectiveness, consequently reducing blood sugar. Always follow your physician's prescribed dosage and regimen for DiaBeta Trio. Ingestion with food is recommended to minimize digestive discomfort. Missed doses should be taken promptly unless the next dose is imminent; in such cases, omit the missed dose and resume the regular schedule. Never double the dose. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or meal skipping elevates the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be assessed before prescription. Limit alcohol consumption as it can intensify certain side effects.
Primary Ingredients of Glufin P 1mg/500mg/15mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Glufin P 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glufin P 1mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Glufin P 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
Common Side effects of Glufin P 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glufin P 1mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the Glufin P 1mg/500mg/15mg tablet whole; do not chew, crush, or fracture it. Administer this medication with food.
How Glufin P 1mg/500mg/15mg Tablet works:
Glufin P tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple combination enhances blood glucose management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glufin P 1mg/500mg/15mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glufin P 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Glufin P 1mg/500mg/15mg tablets are likely incompatible. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glufin P 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. The use of Glufin P 1mg/500mg/15mg tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glufin P 1mg/500mg/15mg tablets cautiously, potentially requiring dose modification. Consult a physician before use. Glufin P 1mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glufin P 1mg/500mg/15mg Tablet :
Should you forget to take your Glufin P 1mg/500mg/15mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glufin P 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
